SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors digest an earnings beat led by strong Azure growth, with the market focusing on the company's ability to maintain high AI capital expenditures while showing path to profitability. Community members are actively debating whether these results signal a broader rotation into quality software names or if recent stock volatility and macro uncertainties will continue to weigh on the sector.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure as investors react to a profit miss driven by aggressive capital expenditure on AI and unexpected legal and restructuring costs. The community is sharply divided, with some investors criticizing Zuckerberg's spending strategy and questioning the near-term returns on infrastructure, while others view the stock as a discounted long-term opportunity, actively debating the support levels and potential for a rebound.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is experiencing intense volatility as investors react to a combination of disappointing mega-cap earnings reports, rising geopolitical tensions in the Middle East, and broader concerns over AI capex sustainability. The community is deeply divided, with many traders debating whether current price action represents a classic bear trap or the beginning of a deeper deleveraging cycle driven by international market instability.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are fixated on high bond yields, geopolitical volatility, and the aftermath of the latest Fed meeting, which has spurred intense debate over the sustainability of current AI-related capital expenditures. The community remains deeply divided, with many traders expressing frustration over rapid intraday reversals and extreme volatility while debating whether major tech earnings will provide a lasting floor or merely a temporary reprieve.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio Inc. (IBRX) is trending after securing broad marketing authorization in the UAE for its immunotherapy, ANKTIVA, which the community views as a critical step in global commercial expansion. Investors are actively debating the timing of this news versus potential future partnership announcements, while others are focusing on the stock's high short interest and the upcoming earnings report as key catalysts for near-term price action.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya is trending as investors capitalize on record-breaking ABS issuance and improving balance sheet metrics, despite ongoing volatility from broader fintech sector headwinds and geopolitical concerns. The community is heavily focused on the company's profitability, recent insider share purchases by the CEO, and the potential for a technical breakout if the stock can sustain momentum above key resistance levels.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings is facing significant volatility as investors weigh the company's long-term position in the AI infrastructure and liquid cooling sector against a recent revenue timing miss. While management maintains strong confidence due to a robust project pipeline and raised guidance, the community is currently debating whether the recent price decline represents a long-term accumulation opportunity or a signal of broader valuation exhaustion in AI-related stocks.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is facing significant market volatility as investors weigh the potential of federal funding and quantum sector growth against ongoing concerns regarding high cash burn, significant share price dilution, and long-term path to profitability. The community remains deeply divided, with bulls pointing to strategic government partnerships as validation for long-term holds, while vocal bears argue the stock's recent performance is a classic pump-and-dump cycle driven by speculative hype.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is facing significant market volatility as investors weigh the positive implications of a recent FDA advisory panel's support for peptide compounding against regulatory concerns, including an FTC lawsuit regarding billing and privacy practices. The community is deeply divided, with some investors dismissing the legal challenges as routine industry noise and 'Big Pharma' interference, while others worry about the potential impact on growth and long-term governance.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as bond markets react to persistent inflationary pressures from rising energy costs and geopolitical tension in the Middle East, leading investors to scrutinize the Federal Reserve's restrictive policy stance. Community discussion remains polarized, with many traders debating whether long-term Treasury yields have reached a sustainable peak or if further spikes will continue to pressure equity valuations and exacerbate debt service concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 29, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no...

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid advances in personalized medicine and synthetic biology continue to transform the industry.

Sana (SANA) Upgraded to Buy: Here's What You Should Know

Sana (SANA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy

The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy PR Newswire LAS VEGAS, July...

Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 2, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost...

Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum

Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum Anti-Aging Cell Therapy Reaches Major GMP Milestone as Wave of Clinical Advancements Gain Momentum PR Newswire NEW YORK, May 28, 2026 USA News Group News CommentaryIssued on behalf ofAva Bio, Inc.As...

Sana Biotechnology (NASDAQ:SANA) Shares Down 7.3% - Time to Sell?

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 7.3% - Here's What Happened...

Wall Street Zen Downgrades Sana Biotechnology (NASDAQ:SANA) to Strong Sell

Wall Street Zen lowered Sana Biotechnology from a "sell" rating to a "strong sell" rating in a research note on Saturday...

Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7% - What's Next?

Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7% - Here's Why...

Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of "Moderate Buy" from Analysts

Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are presently covering the company, MarketBeat.com...

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Sana Biotechnology Inc

SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.17
Prev Close	$3.29
Open	$3.28
Dividend Yield	0.00%
50-Day Moving Average	$3.25
Beta	1.98
Avg. Volume	3.98M
PE Ratio	-3.38

52-Week High	$6.55
52-Week Low	$2.61
Market Capitalization	$915.58M
EPS (Annual)	-$0.9642
Price to Book	7.17
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

SANASana Biotechnology Inc

Latest SANA News